MiR-103 decreased early in Alzheimer's disease and accelerated disease progression through the regulation of BACE1 (β-site amyloid precursor protein-cleaving enzyme 1) [57]. This evidence concerns the gene BACE1 and early-onset autosomal dominant Alzheimer disease.